David Young
Pres. Research & Development at Processa Pharmaceuticals, Inc. (PCSA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$13K
Total bought / sold$32K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 1SEC | PCSAProcessa Pharmaceuticals, Inc. | Buy | 2,53121,729 held (+13%) | $1.93 | $5K | -21.2% |
| Jun 16SEC | PCSAProcessa Pharmaceuticals, Inc. | Buy | 2,06719,198 held (+12%) | $2.22 | $5K | -31.5% |
| Jun 1SEC | PCSAProcessa Pharmaceuticals, Inc. | Buy | 1,78617,131 held (+12%) | $2.57 | $5K | -40.9% |
| May 19SEC | PCSAProcessa Pharmaceuticals, Inc. | Buy | 1,54515,345 held (+11%) | $2.97 | $5K | -48.8% |
| May 1SEC | PCSAProcessa Pharmaceuticals, Inc. | Buy | 1,70613,813 held (+14%) | $2.69 | $5K | -43.5% |
| Apr 17SEC | PCSAProcessa Pharmaceuticals, Inc. | Buy | 1,54512,107 held (+15%) | $2.97 | $5K | -48.8% |
| Apr 1SEC | PCSAProcessa Pharmaceuticals, Inc. | Buy | 1,81010,562 held (+21%) | $2.54 | $5K | -40.2% |
- Buy
Pres. Research & Development David Young bought $5K of PCSA at $1.93 — largest purchase by this insider in our records.
- Buy
Pres. Research & Development David Young bought $5K of PCSA at $2.54 — first open-market purchase in our records; raises the stake by 21%.